US Pharma MarketingVertex makes its largest-ever deal, skyrocketing health insurance costs, and more biotech news from The Readout patients research rare diseases Newsletters Log In My Account Subscribe Now My Account Settings Complete your personal information for a more tailored experience Billing Log Out A decade of reporting from the frontiers of health and medicine Newsletters Log In My Account Subscribe Now Biotech Pharma Public Health Health Tech Policy Science First Opinion STAT+ STAT Events Search Log In Try STAT+ My Account Home Newsletter The Readout Compass says depression drug has long-lasting benefits Vertex makes its largest-ever deal, skyrocketing health insurance costs,…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. Plenty of news today, and also a deal that is running out soon: Buy one year of STAT+, get one year free.
Vertex said yesterday it will spend $10 billion to acquire Crinetics Pharmaceuticals, a biotech developing drugs for rare endocrine disorders.
Source: STAT News Pharma